| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 01/20/1999 | EP0892059A2 Histidine kinase polypeptides |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
| 01/20/1999 | EP0892055A2 GidB polypeptides from Staphylococcus aureus |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891983A1 Novel tarF |
| 01/20/1999 | EP0891771A1 Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases |
| 01/20/1999 | EP0891770A1 Killer T cell activator and use thereof |
| 01/20/1999 | EP0891428A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891331A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity |
| 01/20/1999 | EP0871440A4 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 01/20/1999 | EP0675714B1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR |
| 01/20/1999 | EP0445228B1 Immunotherapy involving cd28 stimulation |
| 01/20/1999 | CN1205707A Sugar-substituted 2-azetidinones useful as hypocholesterolemic gents |
| 01/20/1999 | CN1205641A Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861434 Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders |
| 01/19/1999 | US5861389 Treating male menopause |
| 01/19/1999 | US5861312 Recognition component; hybridization; dna expression vectors; genetic engineering |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861168 Vessels suffering vascular injury from angioplasty are treated with arginine or lysine to reduce probabilty of restenosis |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | US5860950 Arthroscopic irrigation solution and method for inhibition of pain and inflammation |
| 01/19/1999 | CA2121484C Treatment of acne or of pseudofolliculitis barbae |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/18/1999 | CA2237160A1 Gida1 |
| 01/18/1999 | CA2237147A1 Novel ratb |
| 01/18/1999 | CA2237143A1 Novel rata |
| 01/18/1999 | CA2237140A1 Novel tarf |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001764A2 METHOD FOR DETERMINING GnRH RECEPTORS |
| 01/14/1999 | WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 01/14/1999 | WO1999001498A1 Conjugate of polyethylene glycol and chitosan |
| 01/14/1999 | WO1999001464A1 Componds and methods for treating and screening viral reactivation |
| 01/14/1999 | WO1999001463A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 01/14/1999 | WO1999001149A1 Health supplement |
| 01/14/1999 | WO1999001143A1 Cross-linked polysaccharide drug carrier |
| 01/14/1999 | WO1999001142A1 Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan |
| 01/14/1999 | WO1999001124A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 01/14/1999 | WO1999001118A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 01/14/1999 | WO1999001117A2 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | WO1999001114A1 Prolonged anesthesia in joints and body spaces |
| 01/14/1999 | WO1999001110A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 01/14/1999 | WO1999001033A1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 01/14/1999 | WO1998039029A3 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 01/14/1999 | WO1998035020A3 Methods for modulating hematopoiesis and vascular growth |
| 01/14/1999 | CA2297791A1 Health supplement |
| 01/14/1999 | CA2295933A1 Compounds and methods for treating and screening viral reactivation |
| 01/14/1999 | CA2294900A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 01/14/1999 | CA2294764A1 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | CA2289453A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890644A2 MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase |
| 01/13/1999 | EP0890641A1 Novel IspA |
| 01/13/1999 | EP0889971A1 Phosphatase modulator |
| 01/13/1999 | EP0889906A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 01/13/1999 | EP0889905A1 Cytokine antagonists and agonists |
| 01/13/1999 | EP0889888A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889880A1 Eprosartan dihydrate and a process for its production and formulation |
| 01/13/1999 | EP0889731A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 01/13/1999 | EP0889727A1 Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
| 01/13/1999 | EP0789567A4 A method for treating vascular headaches |
| 01/13/1999 | EP0671910A4 Glaucoma treatment. |
| 01/13/1999 | CN1204961A Eyedrops |
| 01/13/1999 | CN1204960A Novel stable preparation use paracetamol as base and method for preparing same |
| 01/13/1999 | CN1204518A Medicine for reducing pathologic raised beta-receptor and its producing tehcnology |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859065 Treatment method for cancer |
| 01/12/1999 | US5859058 Administering ng-monomethyl-l-arginine |
| 01/12/1999 | US5859050 Method for the preparation of (+)-calanolide A and analogues thereof |
| 01/12/1999 | US5859049 Calanolide and related antiviral compounds, compositions, and uses thereof |
| 01/12/1999 | US5859031 Small molecule inhibitors of rotamase enzyme activity |
| 01/12/1999 | US5859021 Antiviral combinations |
| 01/12/1999 | US5858758 Human serine protease precursor |
| 01/12/1999 | US5858753 Purified, isolated polynucleotide coding catalytic subunit polypeptide similar to phosphatidylinisitol 3-kinase; anticancer agents; antiproliferative agents |
| 01/12/1999 | US5858720 Hiss |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858715 Polynucleotide sequence for antisense agents, hybridization probes and diagnosis of diseases; anticancer agents; antiischemic agents; alzheimer's/parkinson's diseases |
| 01/12/1999 | US5858708 For genetically engineered expression vectors in host cells, antisense molecules, and diagnosis and treatment of nervous system degenerative disorders such as amyotrophic lateral sclerosis |
| 01/12/1999 | US5858683 Determining presence of non-chromatin protein in biological sample (pap smears) by immunoassay or two-dimensional electrophoresis; accurate rapid diagnosis before metastasis occurs |
| 01/12/1999 | US5858402 Administering physiologically compatible transition metal chelate of dithiocarbamate-containing cyanide scavenger |
| 01/12/1999 | US5858365 Administering butyric acid and an amino acid, heptafluorobutyric acid, 3-chloropropionic acid, beta-chloro-l-alanine hydrochloride and isobutyramide for ulcers |
| 01/12/1999 | US5858360 Mediate embryo-endometrium adhesion; anti-trophinin antibodies for inhibition; trophinin-assisting proteins tastin, bystin, lastin for increasing binding; endometrial adenocarcinoma |
| 01/12/1999 | US5858344 Oral administration form having acid active substances and a process for its production |
| 01/12/1999 | US5858017 Urologic irrigation solution and method for inhibition of pain, inflammation and spasm |
| 01/12/1999 | CA2104917C Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |